D

Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192

Watchlist Manager
Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192
Watchlist
Price: 46.18 CNY -3.27%
Market Cap: 19.2B CNY
Have any thoughts about
Dizal Jiangsu Pharmaceutical Co Ltd?
Write Note

Dizal Jiangsu Pharmaceutical Co Ltd
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Dizal Jiangsu Pharmaceutical Co Ltd
Operating Expenses Peer Comparison

Comparables:
6160
603392
002252
300122
300896

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
D
Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192
Operating Expenses
-ÂĄ1.2B
CAGR 3-Years
-17%
CAGR 5-Years
-44%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Operating Expenses
-ÂĄ23.5B
CAGR 3-Years
-22%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Operating Expenses
-ÂĄ3.1B
CAGR 3-Years
-41%
CAGR 5-Years
-42%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Operating Expenses
-ÂĄ954.2m
CAGR 3-Years
-6%
CAGR 5-Years
2%
CAGR 10-Years
-19%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Operating Expenses
-ÂĄ4.6B
CAGR 3-Years
-29%
CAGR 5-Years
-28%
CAGR 10-Years
-30%
Imeik Technology Development Co Ltd
SZSE:300896
Operating Expenses
-ÂĄ649m
CAGR 3-Years
-53%
CAGR 5-Years
-35%
CAGR 10-Years
N/A

See Also

What is Dizal Jiangsu Pharmaceutical Co Ltd's Operating Expenses?
Operating Expenses
-1.2B CNY

Based on the financial report for Dec 31, 2023, Dizal Jiangsu Pharmaceutical Co Ltd's Operating Expenses amounts to -1.2B CNY.

What is Dizal Jiangsu Pharmaceutical Co Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-44%

Over the last year, the Operating Expenses growth was -54%. The average annual Operating Expenses growth rates for Dizal Jiangsu Pharmaceutical Co Ltd have been -17% over the past three years , -44% over the past five years .

Back to Top